Aies Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 05-07-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.13 Cr
as on 05-07-2024
- Revenue %
(FY 2021)
- Net Worth -88.25%
(FY 2021)
- Total Assets 32.54%
(FY 2021)
About Aies Pharma Chem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹4.13 Cr.
Narendra Pakhawala, Mrugesh Modi, Jitendrakumar Modi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24304GJ2018PTC103237
- Company No.
103237
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aies Pharma Chem?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Pakhawala  | Additional Director | 05-Dec-2018 | Current |
| Mrugesh Modi | Director | 12-Jul-2018 | Current |
| Jitendrakumar Modi | Director | 12-Jul-2018 | Current |
| Siddharth Patel | Additional Director | 05-Dec-2018 | Current |
| Manibhai Patel | Additional Director | 05-Dec-2018 | Current |
Financial Performance and Corporate Structure Insights of Aies Pharma Chem.
Aies Pharma Chem Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 88.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aies Pharma Chem?
Unlock access to Aies Pharma Chem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 10 Jan 2020 | ₹4.13 Cr | Open |
How Many Employees Work at Aies Pharma Chem?
Unlock and access historical data on people associated with Aies Pharma Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aies Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aies Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
